Cardiology

Results from the COBRA-REDUCE trial reported

For patients undergoing percutaneous coronary intervention (PCI) that also require oral anticoagulation, treatment with a nanotechnology polymer-coated stent plus 14-day dual anti-platelet therapy (DAPT) did not reduce bleeding ...

Cardiology

Results from host-reduce-polytech-ACS trial reported

A randomized clinical trial found that drug-eluting stents (DES) with durable polymers are non-inferior to DES with biodegradable polymers in patients with acute coronary syndrome (ACS).

Genetics

CYP2C19 genotyping may aid antiplatelet prescribing

(HealthDay)—Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention (PCI), according to a study published in the Aug. 25 issue of the ...

Cardiology

International registries show PCI rates increased in Japan, US

Japan and the U.S. have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in ...

Diseases, Conditions, Syndromes

ST-segment elevation described in patients with COVID-19

(HealthDay)—For patients with COVID-19 who have ST-segment elevation, indicating potential acute myocardial infarction, there is considerable variability in presentation, and prognosis is poor, according to a letter to ...

page 1 from 30